• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Geron Corp (NQ: GERN )

    4.595 -0.025 (-0.54%)
    Streaming Delayed Price Updated: 11:50 AM EDT, Aug 21, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Geron Corp

    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Geron Corporation
    Via Business Wire
    Geron (GERN) Q1 2023 Earnings Call Transcript
    GERN earnings call for the period ending March 31, 2023. 
    Via The Motley Fool
    Geron Presentations at Upcoming EHA Annual Meeting to Report Updated Durability, Disease Modification and Favorable Patient Reported Outcomes (PRO) in Imetelstat-Treated Lower Risk MDS Patients in IMerge Phase 3
    From Geron Corporation
    Via Business Wire
    Recap: Geron Q1 Earnings
    Via Benzinga
    A Preview Of Geron's Earnings
    Via Benzinga
    Looking Into Geron's Return On Capital Employed
    Via Benzinga
    The Latest Analyst Ratings for Geron
    Via Benzinga
    Geron (GERN) Q4 2022 Earnings Call Transcript
    GERN earnings call for the period ending December 31, 2022. 
    Via The Motley Fool
    Geron Corporation Reports First Quarter 2023 Financial Results and Business Highlights
    From Geron Corporation
    Via Business Wire
    Geron to Announce First Quarter 2023 Financial Results on May 11, 2023
    From Geron Corporation
    Via Business Wire
    Geron Announces Upcoming Oral Presentation at 2023 American Society of Clinical Oncology Annual Meeting of Imetelstat Data from IMerge Phase 3 Lower Risk MDS Trial
    From Geron Corporation
    Via Business Wire
    Earnings Outlook For Geron
    Via Benzinga
    2 Top Healthcare Stocks to Buy Right Now
    One has a breakout drug, the other a nice-sized moat. 
    Via The Motley Fool
    Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Geron Corporation
    Via Business Wire
    Why Shares of Geron Are Up 30% This Week
    The company's CEO was scheduled to speak at a virtual conference on Thursday. 
    Via The Motley Fool
    Geron to Present at Upcoming Investor Conferences in April
    From Geron Corporation
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For March 28, 2023
    Via Benzinga
    7 Biotech Stocks Sitting in the Sweet Spot
    Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable. 
    Via InvestorPlace
    Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Geron Corporation
    Via Business Wire
    Geron Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and Upcoming Milestones
    From Geron Corporation
    Via Business Wire
    Geron to Announce Fourth Quarter and Full-Year 2022 Financial Results on March 16, 2023
    From Geron Corporation
    Via Business Wire
    SMID Cap Life Science Update: Are You An Investor Or Trader?
    Despite choppy trading, there is an upward tilt to life science stocks since the 9/26/22 lows. 
    Via Talk Markets
    7 A-Rated Penny Stocks Worth Betting On
    Penny stocks tend to be more volatile than more so-called “established” stocks, so you have to be comfortable with your risk tolerance. 
    Via InvestorPlace
    Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Geron Corporation
    Via Business Wire
    7 A-Rated Healthcare Stocks to Buy for the Future of Medicine
    Snapping up or adding to your positions in these healthcare stocks could be just what the doctor ordered for your portfolio. 
    Via InvestorPlace
    7 A-Rated Stocks to Buy for February 2023
    Now's the time to pounce on these seven high-quality stocks to buy; each one earns an A rating in Portfolio Grader. 
    Via InvestorPlace
    When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
    A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy? 
    Via Talk Markets
    7 A-Rated Stocks to Buy for Less Than $25
    These seven stocks to buy for less than $25 per share are strong opportunities in today's resilient yet uncertain market. 
    Via InvestorPlace
    Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Geron Corporation
    Via Business Wire
    Geron to Present at the B. Riley Securities 3rd Annual Virtual Oncology Conference
    From Geron Corporation
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.